ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,806Medicare Part D Prescriptions Filled, Including Refills

Rank: 203 out of 680

$580K Total Retail Price of All Prescriptions

Rank: 228 out of 680

698 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 698 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 698 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 655 542 1 5
AMLODIPINE BESYLATE 641 516 2 1
SIMVASTATIN 567 488 3 3
LEVOTHYROXINE SODIUM 324 262 4 2
METFORMIN HCL 261 204 5 8
LOVASTATIN 247 180 6 44
ATENOLOL 234 200 7 19
ATORVASTATIN CALCIUM 228 200 8 11
METOPROLOL SUCCINATE 220 167 9 13
OMEPRAZOLE 213 163 10 7
NEXIUM 191 122 11 16
HYDROCODONE-ACETAMINOPHEN 189 115 S3 12 4
LOSARTAN POTASSIUM 185 161 13 21
FUROSEMIDE 183 135 14 6
METOPROLOL TARTRATE 159 129 15 12
MELOXICAM 158 147 16 24
ZOLPIDEM TARTRATE 148 137 17 17
HYDROCHLOROTHIAZIDE 148 132 17 9
CITALOPRAM HBR 146 121 19 22
PRAVASTATIN SODIUM 122 89 20 10
SERTRALINE HCL 112 102 21 28
TRIAMTERENE-HCTZ 102 68 22 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 91 23 37
POTASSIUM CHLORIDE 95 83 24 14
SYNTHROID 92 92 25 38
TRAMADOL HCL 91 57 26 18
FLUOXETINE HCL 90 90 27 74
CARVEDILOL 86 65 28 23
GLIPIZIDE 84 74 29 63
DONEPEZIL HCL 84 84 29 27
DIOVAN 83 78 31 31
TAMSULOSIN HCL 81 70 32 34
BENAZEPRIL HCL 79 55 33 40
GABAPENTIN 77 70 34 15
ALLOPURINOL 75 69 35 33
DOXYCYCLINE HYCLATE 72 53 36 95
CLOPIDOGREL 72 57 36 26
WARFARIN SODIUM 71 52 38 20
NAMENDA 69 69 39 35
AZITHROMYCIN 68 50 40 42
CRESTOR 67 56 41 25
CARISOPRODOL 65 12 R 42 83
RAMIPRIL 64 63 43 69
ESCITALOPRAM OXALATE 64 64 43 45
GLIMEPIRIDE 63 50 45 29
HYDRALAZINE HCL 61 41 46 71
CIPROFLOXACIN HCL 61 47 46 57
LOSARTAN-HYDROCHLOROTHIAZIDE 60 47 48 51
PLAVIX 60 54 48 39
FLUTICASONE PROPIONATE 60 47 48 41
TERAZOSIN HCL 58 45 51 180
PEN NEEDLE 57 30 52 122
METFORMIN HCL ER 55 55 53 54
LIPITOR 55 46 53 68
LANTUS SOLOSTAR 52 36 55 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.